APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biothrax (Anthrax Vaccine)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biothrax (Anthrax Vaccine) Industry Growth and Trends Forecast to 2032

2 January 2026124 pages

Choose your research edition.

Industry ResearchBiothrax (Anthrax Vaccine) Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Biothrax (Anthrax Vaccine) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Biothrax (Anthrax Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biothrax (Anthrax Vaccine) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Biothrax (Anthrax Vaccine) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Biothrax (Anthrax Vaccine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biothrax (Anthrax Vaccine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biothrax (Anthrax Vaccine) include Merck, Tiankang, Zoetis, Vecol, Rosenbusch, Prondil, PharmAthene, Merial and JOVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biothrax (Anthrax Vaccine) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biothrax (Anthrax Vaccine) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biothrax (Anthrax Vaccine) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biothrax (Anthrax Vaccine).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biothrax (Anthrax Vaccine) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biothrax (Anthrax Vaccine) Market by Company

Merck

Tiankang

Zoetis

Vecol

Rosenbusch

Prondil

PharmAthene

Merial

JOVAC

IVPM

Intervac

Indian Immunologicals

CVCRI

Colorado Serum

Ceva Santé Animale

CDV

CAVAC

Botswana Vaccine Institute

Biogénesis-Bago

Bayer Sanidad Animal

Agrovet

Biothrax (Anthrax Vaccine) Segment by Type

Live Vaccines

Cell Free PA Vaccines

Biothrax (Anthrax Vaccine) Segment by Application

Human Use

Animal Use

Biothrax (Anthrax Vaccine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biothrax (Anthrax Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biothrax (Anthrax Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biothrax (Anthrax Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biothrax (Anthrax Vaccine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Cell Free PA Vaccines Table 3. Global Biothrax (Anthrax Vaccine) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 5. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type (2021-2026) Table 8. Global Biothrax (Anthrax Vaccine) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 10. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type (2027-2032) Table 13. Global Biothrax (Anthrax Vaccine) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 15. North America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 17. Europe Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (US$ Million) Table 24. Biothrax (Anthrax Vaccine) Industry Trends Table 25. Biothrax (Anthrax Vaccine) Industry Drivers Table 26. Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges Table 27. Biothrax (Anthrax Vaccine) Industry Restraints Table 28. Global Biothrax (Anthrax Vaccine) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2021-2026) Table 30. Global Biothrax (Anthrax Vaccine) Sales by Company (2021-2026) & (K Units) Table 31. Global Biothrax (Anthrax Vaccine) Sales Share by Company (2021-2026) Table 32. Global Biothrax (Anthrax Vaccine) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Biothrax (Anthrax Vaccine) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Biothrax (Anthrax Vaccine) Major Company Production Sites and Headquarters Table 35. Global Biothrax (Anthrax Vaccine) Company, Product Type & Application Table 36. Global Biothrax (Anthrax Vaccine) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Biothrax (Anthrax Vaccine) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units) Table 41. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Region (2021-2026) Table 44. Global Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032) & (K Units) Table 46. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Region (2027-2032) Table 49. Global Biothrax (Anthrax Vaccine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Biothrax (Anthrax Vaccine) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 52. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application (2021-2026) Table 55. Global Biothrax (Anthrax Vaccine) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 57. Global Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application (2027-2032) Table 60. Global Biothrax (Anthrax Vaccine) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 62. North America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 64. Europe Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Biothrax (Anthrax Vaccine) Product Portfolio Table 75. Merck Recent Development Table 76. Tiankang Company Information Table 77. Tiankang Business Overview Table 78. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Tiankang Biothrax (Anthrax Vaccine) Product Portfolio Table 80. Tiankang Recent Development Table 81. Zoetis Company Information Table 82. Zoetis Business Overview Table 83. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zoetis Biothrax (Anthrax Vaccine) Product Portfolio Table 85. Zoetis Recent Development Table 86. Vecol Company Information Table 87. Vecol Business Overview Table 88. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vecol Biothrax (Anthrax Vaccine) Product Portfolio Table 90. Vecol Recent Development Table 91. Rosenbusch Company Information Table 92. Rosenbusch Business Overview Table 93. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio Table 95. Rosenbusch Recent Development Table 96. Prondil Company Information Table 97. Prondil Business Overview Table 98. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Prondil Biothrax (Anthrax Vaccine) Product Portfolio Table 100. Prondil Recent Development Table 101. PharmAthene Company Information Table 102. PharmAthene Business Overview Table 103. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio Table 105. PharmAthene Recent Development Table 106. Merial Company Information Table 107. Merial Business Overview Table 108. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Merial Biothrax (Anthrax Vaccine) Product Portfolio Table 110. Merial Recent Development Table 111. JOVAC Company Information Table 112. JOVAC Business Overview Table 113. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. JOVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 115. JOVAC Recent Development Table 116. IVPM Company Information Table 117. IVPM Business Overview Table 118. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. IVPM Biothrax (Anthrax Vaccine) Product Portfolio Table 120. IVPM Recent Development Table 121. Intervac Company Information Table 122. Intervac Business Overview Table 123. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Intervac Biothrax (Anthrax Vaccine) Product Portfolio Table 125. Intervac Recent Development Table 126. Indian Immunologicals Company Information Table 127. Indian Immunologicals Business Overview Table 128. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio Table 130. Indian Immunologicals Recent Development Table 131. CVCRI Company Information Table 132. CVCRI Business Overview Table 133. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. CVCRI Biothrax (Anthrax Vaccine) Product Portfolio Table 135. CVCRI Recent Development Table 136. Colorado Serum Company Information Table 137. Colorado Serum Business Overview Table 138. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio Table 140. Colorado Serum Recent Development Table 141. Ceva Santé Animale Company Information Table 142. Ceva Santé Animale Business Overview Table 143. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio Table 145. Ceva Santé Animale Recent Development Table 146. CDV Company Information Table 147. CDV Business Overview Table 148. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. CDV Biothrax (Anthrax Vaccine) Product Portfolio Table 150. CDV Recent Development Table 151. CAVAC Company Information Table 152. CAVAC Business Overview Table 153. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. CAVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 155. CAVAC Recent Development Table 156. Botswana Vaccine Institute Company Information Table 157. Botswana Vaccine Institute Business Overview Table 158. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio Table 160. Botswana Vaccine Institute Recent Development Table 161. Biogénesis-Bago Company Information Table 162. Biogénesis-Bago Business Overview Table 163. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio Table 165. Biogénesis-Bago Recent Development Table 166. Bayer Sanidad Animal Company Information Table 167. Bayer Sanidad Animal Business Overview Table 168. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio Table 170. Bayer Sanidad Animal Recent Development Table 171. Agrovet Company Information Table 172. Agrovet Business Overview Table 173. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Agrovet Biothrax (Anthrax Vaccine) Product Portfolio Table 175. Agrovet Recent Development Table 176. North America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 178. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 179. North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032) & (K Units) Table 180. North America Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Country (2027-2032) Table 181. North America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Biothrax (Anthrax Vaccine) Market Share by Country (2021-2026) Table 184. North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Biothrax (Anthrax Vaccine) Market Share Forecast by Country (2027-2032) Table 186. Europe Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 188. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 189. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032) & (K Units) Table 190. Europe Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Biothrax (Anthrax Vaccine) Market Share by Country (2021-2026) Table 194. Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Biothrax (Anthrax Vaccine) Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 198. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032) & (K Units) Table 200. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Biothrax (Anthrax Vaccine) Market Share by Country (2021-2026) Table 204. Asia-Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Biothrax (Anthrax Vaccine) Market Share Forecast by Country (2027-2032) Table 206. Latin America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 208. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 209. Latin America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032) & (K Units) Table 210. Latin America Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Biothrax (Anthrax Vaccine) Market Share by Country (2021-2026) Table 214. Latin America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Biothrax (Anthrax Vaccine) Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 218. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032) & (K Units) Table 220. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Biothrax (Anthrax Vaccine) Market Share by Country (2021-2026) Table 224. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Biothrax (Anthrax Vaccine) Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Biothrax (Anthrax Vaccine) Distributors List Table 229. Biothrax (Anthrax Vaccine) Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Biothrax (Anthrax Vaccine) Image Figure 2. Global Biothrax (Anthrax Vaccine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biothrax (Anthrax Vaccine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Biothrax (Anthrax Vaccine) Sales (2021-2032) & (K Units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cell Free PA Vaccines Image Figure 8. Global Cell Free PA Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Biothrax (Anthrax Vaccine) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Biothrax (Anthrax Vaccine) Market Share by Type 2025 VS 2032 Figure 11. North America Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type in 2025 Figure 12. North America Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type in 2025 Figure 13. Europe Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Biothrax (Anthrax Vaccine) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Human Use Image Figure 24. Global Human Use Sales YoY Growth (2021-2032) & (K Units) Figure 25. Animal Use Image Figure 26. Global Animal Use Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Biothrax (Anthrax Vaccine) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Biothrax (Anthrax Vaccine) Market Share by Application 2025 VS 2032 Figure 29. North America Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application in 2025 Figure 30. North America Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application in 2025 Figure 31. Europe Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share in Value by Application in 2025 Figure 39. North America Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Biothrax (Anthrax Vaccine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Biothrax (Anthrax Vaccine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Biothrax (Anthrax Vaccine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Biothrax (Anthrax Vaccine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Biothrax (Anthrax Vaccine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Biothrax (Anthrax Vaccine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Biothrax (Anthrax Vaccine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Biothrax (Anthrax Vaccine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Biothrax (Anthrax Vaccine) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Biothrax (Anthrax Vaccine) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Cell Free PA Vaccines
Applications
  • Human Use
  • Animal Use
Companies covered
  • Merck
  • Tiankang
  • Zoetis
  • Vecol
  • Rosenbusch
  • Prondil
  • PharmAthene
  • Merial
  • JOVAC
  • IVPM
  • Intervac
  • Indian Immunologicals
  • CVCRI
  • Colorado Serum
  • Ceva Santé Animale
  • CDV
  • CAVAC
  • Botswana Vaccine Institute
  • Biogénesis-Bago
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biothrax (Anthrax Vaccine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biothrax (Anthrax Vaccine) Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Cell Free PA Vaccines
  8. 1.4 Global Biothrax (Anthrax Vaccine) Market Size by Type
  9. 1.4.1 Global Biothrax (Anthrax Vaccine) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Biothrax (Anthrax Vaccine) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Biothrax (Anthrax Vaccine) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biothrax (Anthrax Vaccine) Industry Trends
  2. 2.2 Biothrax (Anthrax Vaccine) Industry Drivers
  3. 2.3 Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges
  4. 2.4 Biothrax (Anthrax Vaccine) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biothrax (Anthrax Vaccine) Revenue (2021-2026)
  2. 3.2 Global Top Players by Biothrax (Anthrax Vaccine) Sales (2021-2026)
  3. 3.3 Global Top Players by Biothrax (Anthrax Vaccine) Price (2021-2026)
  4. 3.4 Global Biothrax (Anthrax Vaccine) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biothrax (Anthrax Vaccine) Major Company Production Sites & Headquarters
  6. 3.6 Global Biothrax (Anthrax Vaccine) Company, Product Type & Application
  7. 3.7 Global Biothrax (Anthrax Vaccine) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biothrax (Anthrax Vaccine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biothrax (Anthrax Vaccine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biothrax (Anthrax Vaccine) Tier 1, Tier 2, and Tier 3
4 Biothrax (Anthrax Vaccine) Regional Status and Outlook
  1. 4.1 Global Biothrax (Anthrax Vaccine) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biothrax (Anthrax Vaccine) Historic Market Size by Region
  3. 4.2.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biothrax (Anthrax Vaccine) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biothrax (Anthrax Vaccine) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biothrax (Anthrax Vaccine) Forecasted Market Size by Region
  7. 4.3.1 Global Biothrax (Anthrax Vaccine) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biothrax (Anthrax Vaccine) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biothrax (Anthrax Vaccine) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biothrax (Anthrax Vaccine) by Application
  1. 5.1 Biothrax (Anthrax Vaccine) Market by Application
  2. 5.1.1 Human Use
  3. 5.1.2 Animal Use
  4. 5.2 Global Biothrax (Anthrax Vaccine) Market Size by Application
  5. 5.2.1 Global Biothrax (Anthrax Vaccine) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Biothrax (Anthrax Vaccine) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Biothrax (Anthrax Vaccine) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Tiankang
  8. 6.2.1 Tiankang Company Information
  9. 6.2.2 Tiankang Business Overview
  10. 6.2.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
  12. 6.2.5 Tiankang Recent Developments
  13. 6.3 Zoetis
  14. 6.3.1 Zoetis Company Information
  15. 6.3.2 Zoetis Business Overview
  16. 6.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
  18. 6.3.5 Zoetis Recent Developments
  19. 6.4 Vecol
  20. 6.4.1 Vecol Company Information
  21. 6.4.2 Vecol Business Overview
  22. 6.4.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
  24. 6.4.5 Vecol Recent Developments
  25. 6.5 Rosenbusch
  26. 6.5.1 Rosenbusch Company Information
  27. 6.5.2 Rosenbusch Business Overview
  28. 6.5.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
  30. 6.5.5 Rosenbusch Recent Developments
  31. 6.6 Prondil
  32. 6.6.1 Prondil Company Information
  33. 6.6.2 Prondil Business Overview
  34. 6.6.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
  36. 6.6.5 Prondil Recent Developments
  37. 6.7 PharmAthene
  38. 6.7.1 PharmAthene Company Information
  39. 6.7.2 PharmAthene Business Overview
  40. 6.7.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
  42. 6.7.5 PharmAthene Recent Developments
  43. 6.8 Merial
  44. 6.8.1 Merial Company Information
  45. 6.8.2 Merial Business Overview
  46. 6.8.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
  48. 6.8.5 Merial Recent Developments
  49. 6.9 JOVAC
  50. 6.9.1 JOVAC Company Information
  51. 6.9.2 JOVAC Business Overview
  52. 6.9.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
  54. 6.9.5 JOVAC Recent Developments
  55. 6.10 IVPM
  56. 6.10.1 IVPM Company Information
  57. 6.10.2 IVPM Business Overview
  58. 6.10.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
  60. 6.10.5 IVPM Recent Developments
  61. 6.11 Intervac
  62. 6.11.1 Intervac Company Information
  63. 6.11.2 Intervac Business Overview
  64. 6.11.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
  66. 6.11.5 Intervac Recent Developments
  67. 6.12 Indian Immunologicals
  68. 6.12.1 Indian Immunologicals Company Information
  69. 6.12.2 Indian Immunologicals Business Overview
  70. 6.12.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
  72. 6.12.5 Indian Immunologicals Recent Developments
  73. 6.13 CVCRI
  74. 6.13.1 CVCRI Company Information
  75. 6.13.2 CVCRI Business Overview
  76. 6.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
  78. 6.13.5 CVCRI Recent Developments
  79. 6.14 Colorado Serum
  80. 6.14.1 Colorado Serum Company Information
  81. 6.14.2 Colorado Serum Business Overview
  82. 6.14.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
  84. 6.14.5 Colorado Serum Recent Developments
  85. 6.15 Ceva Santé Animale
  86. 6.15.1 Ceva Santé Animale Company Information
  87. 6.15.2 Ceva Santé Animale Business Overview
  88. 6.15.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
  90. 6.15.5 Ceva Santé Animale Recent Developments
  91. 6.16 CDV
  92. 6.16.1 CDV Company Information
  93. 6.16.2 CDV Business Overview
  94. 6.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
  96. 6.16.5 CDV Recent Developments
  97. 6.17 CAVAC
  98. 6.17.1 CAVAC Company Information
  99. 6.17.2 CAVAC Business Overview
  100. 6.17.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
  102. 6.17.5 CAVAC Recent Developments
  103. 6.18 Botswana Vaccine Institute
  104. 6.18.1 Botswana Vaccine Institute Company Information
  105. 6.18.2 Botswana Vaccine Institute Business Overview
  106. 6.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
  108. 6.18.5 Botswana Vaccine Institute Recent Developments
  109. 6.19 Biogénesis-Bago
  110. 6.19.1 Biogénesis-Bago Company Information
  111. 6.19.2 Biogénesis-Bago Business Overview
  112. 6.19.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
  114. 6.19.5 Biogénesis-Bago Recent Developments
  115. 6.20 Bayer Sanidad Animal
  116. 6.20.1 Bayer Sanidad Animal Company Information
  117. 6.20.2 Bayer Sanidad Animal Business Overview
  118. 6.20.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
  120. 6.20.5 Bayer Sanidad Animal Recent Developments
  121. 6.21 Agrovet
  122. 6.21.1 Agrovet Company Information
  123. 6.21.2 Agrovet Business Overview
  124. 6.21.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
  126. 6.21.5 Agrovet Recent Developments
7 North America by Country
  1. 7.1 North America Biothrax (Anthrax Vaccine) Sales by Country
  2. 7.1.1 North America Biothrax (Anthrax Vaccine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  4. 7.1.3 North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biothrax (Anthrax Vaccine) Market Size by Country
  6. 7.2.1 North America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026)
  8. 7.2.3 North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
  2. 8.1.1 Europe Biothrax (Anthrax Vaccine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  4. 8.1.3 Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biothrax (Anthrax Vaccine) Market Size by Country
  6. 8.2.1 Europe Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Country
  2. 9.1.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biothrax (Anthrax Vaccine) Market Size by Country
  6. 9.2.1 Asia-Pacific Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biothrax (Anthrax Vaccine) Sales by Country
  2. 10.1.1 South America Biothrax (Anthrax Vaccine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  4. 10.1.3 South America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biothrax (Anthrax Vaccine) Market Size by Country
  6. 10.2.1 South America Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026)
  8. 10.2.3 South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country
  2. 11.1.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biothrax (Anthrax Vaccine) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country
  6. 11.2.1 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biothrax (Anthrax Vaccine) Value Chain Analysis
  2. 12.1.1 Biothrax (Anthrax Vaccine) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biothrax (Anthrax Vaccine) Production Mode & Process
  7. 12.2 Biothrax (Anthrax Vaccine) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biothrax (Anthrax Vaccine) Distributors
  10. 12.2.3 Biothrax (Anthrax Vaccine) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst